gene

HNRNPA2B1

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about HNRNPA2B1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

448Connections
1Hypotheses
1Analyses
50Outgoing
50Incoming

Summary

Page for HNRNPA2B1 - Heterogeneous Nuclear Ribonucleoprotein A2/B1

View on Wiki →

🧬 Gene Info
Gene SymbolHNRNP-A2B1
Full NameHeterogeneous Nuclear Ribonucleoprotein A2/B1 (HNRNPA2B1)
AliasesHNRNPA2B1
Protein TypeGene
Target ClassOther
FunctionGene Symbol: HNRNPA2B1
Mechanism of ActionTherapeutic agents targeting HNRNPA2B1 would work by modulating its RNA-binding activity, preventing pathological protein aggregation, or reducing the formation of cytoplasmic inclusions associated with neurodegeneration. These drugs could utilize antisense oligonucleotides to reduce HNRNPA2B1 expression or small molecules to inhibit its protein-protein interactions and RNA-binding functions.
DruggabilityLow (0.35)
Clinical StagePhase II
Molecular Weight37 kDa
Amino Acids353 aa
NCBI Gene IDSearch NCBI
GeneCardsHNRNP-A2B1
Human Protein AtlasHNRNP-A2B1
Associated DiseasesALS, Alzheimer's Disease, Amorphous Aggregates, Amyotrophic Lateral Sclerosis, Cancer
Known Drugs/CompoundsG-Quadruplex Structured Dna, Single-Stranded Dna, Ionic Strength, Irinotecan, Viral Genome G-Quadruplex
InteractionsIGF2BP1, CSNK2A1, NOTCH1, JUN, RANK, RANKL
SciDEX TargetView Target Profile (1 clinical trials)
SciDEX HypothesesAxonal RNA Transport Reconstitution
KG Connections421 knowledge graph edges
DatabasesGeneCardsUniProtHPASTRING
🔮 Predicted Structure: HNRNPA2B1 — AlphaFold P22626 Click to expand

AI-predicted structure from AlphaFold | Powered by Mol*

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

Heterogeneous Nuclear Ribonucleoprotein A2/B1 (HNRNPA2B1)

gene · 829 words

Progressive Supranuclear Palsy (PSP)

disease · 12907 words

nimodipine-als

clinical_trial · 5778 words

HNRNPA2B1 Protein

protein · 5015 words

TDP-43 Proteinopathy

mechanism · 4112 words

Motor Neuron Disease (MND)

disease · 3843 words

Pathway Diagram

flowchart TD
    HNRNPA2B1["HNRNPA2B1<br/>RNA-binding protein<br/>Ribonucleoprotein"]
    
    %% RNA Processing & Associated Proteins
    HNRNPA1["HNRNPA1<br/>RNA-binding protein"]
    IGF2BP1["IGF2BP1<br/>RNA-binding protein"]
    VALOSIN["VCP/VALOSIN<br/>Protein processing"]
    
    %% Signaling Pathways
    NOTCH1["NOTCH1<br/>Transcription factor"]
    NotchPath["Notch Signaling<br/>Pathway"]
    CSNK2A1["CSNK2A1<br/>Casein kinase"]
    EpiPath["Epigenetic<br/>Regulation"]
    
    %% Neurodegenerative Diseases
    ALS["Amyotrophic Lateral<br/>Sclerosis (ALS)"]
    FTD["Frontotemporal<br/>Dementia"]
    ALZ["Alzheimer's<br/>Disease"]
    MS["Multiple<br/>Sclerosis"]
    Dementia["Dementia<br/>General"]
    NeuroDegeneration["Neurodegeneration<br/>Process"]
    
    %% Inflammatory Process
    Inflammation["Neuroinflammation<br/>Process"]
    
    %% Connections
    HNRNPA2B1 --|"associates with"|--> HNRNPA1
    HNRNPA2B1 --|"interacts with"|--> IGF2BP1
    HNRNPA2B1 --|"associates with"|--> VALOSIN
    
    HNRNPA2B1 --|"activates"|--> CSNK2A1
    HNRNPA2B1 --|"activates"|--> NOTCH1
    HNRNPA2B1 --|"activates"|--> NotchPath
    HNRNPA2B1 --|"inhibits"|--> EpiPath
    
    HNRNPA2B1 --|"activates"|--> ALS
    HNRNPA2B1 --|"activates"|--> ALZ
    HNRNPA2B1 --|"associated with"|--> FTD
    HNRNPA2B1 --|"activates"|--> MS
    HNRNPA2B1 --|"associated with"|--> Dementia
    HNRNPA2B1 --|"activates"|--> NeuroDegeneration
    
    HNRNPA2B1 --|"regulates"|--> Inflammation
    Inflammation --|"contributes to"|--> NeuroDegeneration
    
    NotchPath --|"promotes"|--> NeuroDegeneration
    CSNK2A1 --|"phosphorylates"|--> HNRNPA2B1
    
    %% Styling
    style HNRNPA2B1 fill:#006494
    style HNRNPA1 fill:#4a1a6b
    style IGF2BP1 fill:#4a1a6b
    style VALOSIN fill:#4a1a6b
    style NOTCH1 fill:#4a1a6b
    style NotchPath fill:#ef5350
    style CSNK2A1 fill:#4a1a6b
    style EpiPath fill:#1b5e20
    style ALS fill:#5d4400
    style FTD fill:#5d4400
    style ALZ fill:#5d4400
    style MS fill:#5d4400
    style Dementia fill:#5d4400
    style NeuroDegeneration fill:#ef5350
    style Inflammation fill:#ef5350

Outgoing (328)

TargetRelationTypeStr
Rna Maturationinvolved_inprocess0.95
Mrna Transportinvolved_inprocess0.95
Liquid-Liquid Phase Separationinvolved_inprocess0.95
Dynamic Liquid-Like Dropletsassociated_withphenotype0.95
Rna Bindinginvolved_inprocess0.95

Incoming (120)

SourceRelationTypeStr
CBLdegradesprotein0.92
LNKregulatesprotein0.90
Irinotecaninteracts_withdrug0.90
h-8196b893targets_genehypothesis0.90
Ionic Strengthmodulatescompound0.85

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Axonal RNA Transport Reconstitution 0.446 neurodegeneration RNA binding protein dysregulation across

Mentioning Analyses (1)

Scientific analyses that reference this entity

RNA binding protein dysregulation across ALS FTD and AD

neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.490

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
SIRT6-regulated macrophage efferocytosis epigenetically controls inflammation re [PMID:36593966] Li B, Xin Z, Gao S, Li Y, Guo S, Fu Y, X Theranostics 2023 1
Multisystem proteinopathy: Where myopathy and motor neuron disease converge. [PMID:33145792] Korb MK, Kimonis VE, Mozaffar T Muscle Nerve 2021 1
The role of m6A modification in the biological functions and diseases. [PMID:33611339] Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Signal Transduct Target Ther 2021 1
Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liv [PMID:33213490] Senlin Zhao, Yushuai Mi, Bingjie Guan, B Journal of hematology & oncolo 2020 1
Rare Inherited forms of Paget's Disease and Related Syndromes. [PMID:30756140] Ralston SH, Taylor JP Calcif Tissue Int 2019 1
A LNK-CBL-HNRPA2B1-GPX4 signaling axis mediates dopaminergic neuron vulnerabilit [PMID:41616574] ["Liu Z", "Wang R", "Shen M", "Lan X", " Redox biology 2026 0
Human papillomavirus 16 E6 oncoprotein promotes up-regulation of RNA-binding pro [PMID:41725810] ["Cerasuolo A", "Pecchillo Cimmino T", " Frontiers in microbiology 2026 0
Molecular recognition and induced dimerization of hnRNP A2/B1 truncations by G-q [PMID:41888191] ["Shahatibieke D", "Tang X", "Zheng X", Scientific reports 2026 0
Coordinated Post-Transcriptional Regulation facilitates PD-L1 protein production [PMID:41936857] Chen R, Rajasekaran S, Xing X, Zhang Q, Cancer Lett 2026 0
LncRNA 4930544M13Rik-201 regulates CACNA2D1 expression via interacting with hnRN [PMID:41864512] Fang Z, Liu F, Tang Q, Liu Y, Peng Y, Zh Brain research bulletin 2026 0
Comparative Binding Analysis by Computational Methods and Quartz Crystal Microba [PMID:41728844] ["Volkova O", "Serova A", "Kravtsov V", Journal of chemical informatio 2026 0
Functional Variants of the RAD51 Gene Contribute to Susceptibility to Non-Syndro [PMID:41918261] Guo S, Guo T, Xu Y, Chen R, Wang X Orthodontics & craniofacial re 2026 0
Ligand-specific conformational dynamics and interaction landscapes of hnRNPA2B1 [PMID:41853685] Zhou Z, Li Y, Yang P, Zhu R, Li J, Wu B, Current research in structural 2026 0
Neddylation-Mediated hnRNPA2B1 Degradation Aggravates Retinal Endothelial Cell D [PMID:41773772] Chen TR, Zhou JX, Hou YR, Zhang YN, Li C Investigative ophthalmology & 2026 0
Mechanistic studies on HNRNPA2B1 suggest binding but not selective recognition o [PMID:41662154] ["Park R", "Demny M", "Miller L", "Pedra RNA biology 2026 0
Network medicine modeling of the m⁶A regulatory landscape identifies a KLF6-WTAP [PMID:41787499] Xu C, Zhou Z, Lin Y, Zhang S, Cai S, Li Journal of translational medic 2026 0
Integrative transcriptome-wide association analyses reveal PRKCG-linked GABAergi [PMID:41507195] ["Jin Y", "Cao Y", "Ma W", "Li R", "Li Y Nature communications 2026 0
The Intersection of m6A Methylation and Immune Response in PCOS: A Bioinformatic [PMID:41725222] ["Xu W", "Shi L", "Lu A", "Cui L", "Qian Immunity, inflammation and dis 2026 0
Expression, purification, and biophysical characterization of liquid-liquid phas [PMID:41297573] ["Dur\u00e1n-Armenta L", "Meszaros A", " Protein expression and purific 2026 0
Interaction of tau with HNRNPA2B1 and N6-methyladenosine RNA mediates the progre [PMID:34453888] Jiang L, Lin W, Zhang C, Ash PEA, Verma Molecular cell 2021 0